Tumour Markers in Prostatic Cancer

References

• Silverberg E, Lubera JA. Cancer statistics CA 1989; 39: 3–20, 1989
   PubMed Web of Science ®Google Scholar
• Jensen O M, Esteve H, Moller H, et al. Cancer in the European Community and its member states. Europ J Cancer 1990; 26: 1167–1256
   PubMed Web of Science ®Google Scholar
• Gittes RF. Carcinoma of the prostate. New Eng J Med 1991; 324: 226–244
   Google Scholar
• Cooper JF. The radiochemical measurement of prostatic acid phosphatase: current state of the art. Urol Clin North Amer 1980; 7: 653–665
   PubMedGoogle Scholar
• Vihko P, Lukkarinen O, Kontturi M, et al. Effectiveness of radioimmunoassay of human prostate-specific acid phosphatase in the diagnosis and follow -up of therapy in prostatic carcinoma. Cancer Res 1981; 41: 1180–1183
   PubMed Web of Science ®Google Scholar
• Griffiths J, Rippe D F, Panfili PR. Comparison of enzyme linked immunosorbent assay and radioimmunoassay for prostatic phosphatase in prostatic disease. ClinChem 1982; 28: 183–186
   Google Scholar
• Holle JE. Prostatic acid phosphatase: its current clinical status. J Urol 1987; 138: 1091–1103
   Google Scholar
• Wang M C, Valanzuela L A, Murphy GP, et al. Purification of a human prostatic specific antigen. Invest Urol 1979; 17: 159–163
   PubMedGoogle Scholar
• Haapianen R K, Permi E J, Rannikko S AS, et al. Prostate markers as an aid to staging of prostatic cancer. Brit J. Urol 1990; 65: 264–267
   PubMedGoogle Scholar
• Allhoff E, de Riese W, Efifinger M, et al. Prostate-specific antigen- comparative clinical appreciation of serodiagnostic measure after 8 years of experience. World J Urol 1989; 7: 12–16
   Google Scholar
• Siddall J K, Cooper E H, Newling D WW, et al. An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate. Eur Urol 1986; 12: 123–130
   PubMedGoogle Scholar
• Pontes JE. Biological markers in prostate cancer. J Urol 1983; 130: 1037–1047
   PubMed Web of Science ®Google Scholar
• Ming Chu T. Prostate cancer associated markers in Immunodiagnosis of Cancer2nd edition., RB Herberman, DW Mercer. Marcel Dekker Inc, New York 1990; 339–352
   Google Scholar
• Watt K WK, Lee P J, Mtimkulu T, et al. Human prostate specific antigen: structural and functional similarity with serine proteases. Proc Natl Acad Sci USA 1986; 83: 3166–70
   PubMed Web of Science ®Google Scholar
• Christensson A, Laurell C B, Lilja H. Enzymatic activity of prostate specific antigen and its reactions with extracellular serine proteinase inhibitors. Europ J Biochem 1990; 194: 755–63
   PubMedGoogle Scholar
• Chan D W, Bruek D J, Oesterling JE, et al. Prostatic specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared. ClinChem 1987; 33: 1916–1920
   Google Scholar
• Hortin G L, Bahnson R R, Daft M, et al. Difference in value obtained with 2 assays of prostatic specific antigen. J Urol 1988; 139: 762–765
   PubMed Web of Science ®Google Scholar
• Alfthan H, Stenman UH. False low results obtained with Hybritech RPSA assay. Clin Chem 1988; 34: 2152
   PubMed Web of Science ®Google Scholar
• Stamey T A, Kabalin J N, McNeal JE, et al. Prostate specific antigen in the diagnosis and t reatment of adenocarcinoma of the prostate. II radical prostatectomy treated patients. J Urol 1989; 141: 1076–1083
   PubMed Web of Science ®Google Scholar
• Ferro M A, Barnes I, Roberts J BM, et al. Tumour markers in prostatic carcinoma: a comparison of prostate-specific antigen with acid phosphatase. Br J Urol 1987; 60: 69–73
   PubMedGoogle Scholar
• Armitage T G, Cooper E H, Newling D WW, et al. The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer. Brit J Urol 1988; 62: 584–589
   PubMedGoogle Scholar
• Hudson M A, Bahnson R R, Catalona WJ. Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 1989; 142: 1011–7
   PubMed Web of Science ®Google Scholar
• Lange P H, Ercole C J, Vessella RL. Tumor markers in the follow-up of initial therapy of prostate cancer in Tumor Markers in Prostate Cancer, PH Lange. Excerpta Medica, New York 1986; 16–23
   Google Scholar
• Stamey T A, Kabalin JN. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. untreated patients. J Urol 1989; 141: 1070–1075
   PubMed Web of Science ®Google Scholar
• Lange P H, Ercole C J, Lightner DJ, et al. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989; 141: 873–879
   PubMed Web of Science ®Google Scholar
• Drago JH. The role of new modalities in the early detection and diagnosis of prostate cancer. CA 1989; 39: 326–375
   Google Scholar
• Stamey T A, Kabalin J N, Ferrari M. Prostate specific antigen in the diagnosis and treatment of III. Radiation treated patients. J Urol 1989; 141: 1084–7
   PubMed Web of Science ®Google Scholar
• Kaplan I, Prestidge B R, Cox RS, et al. Prostate specific antigen after irradiation for prostatic carcinoma. J Urol 1990; 144: 1172–5
   PubMedGoogle Scholar
• Emtage L A, Lewis P W, Blackledge G RP. The role of prostate specific antigen in the baseline assessment of patients undergoing hormone therapy for advanced prostate cancer. Br J Urol 1987; 60: 572–577
   PubMedGoogle Scholar
• Killian C S, Yang N, Emrich LJ, et al. Prognostic importance of prostate-specific antigen for the monitoring of patients with stage B2 to Dl prostate cancer. Cancer Res 1985; 45: 886–891
   PubMed Web of Science ®Google Scholar
• Cooper E H, Armitage T G, Robinson M RG, et al. Prostatic specific antigen and the prediction of prognosis in metastatic prostatic cancer. Cancer 1990; 66: 1025–1028
   PubMed Web of Science ®Google Scholar
• Hetherinton J W, Siddall J K, Cooper EH. Contribution of bone scintigraphy, prostatic acid phosphatase and prostate specific antigen to the monitoring of prostatic cancer. Eur Urol 1987; 14: l–5
   Google Scholar
• Shearer RJ. Prostatic specific antigen. Br J Urol 1991; 367: 1–5
   Google Scholar
• Gerber G S, Chodak GW. Routine screening for cancer of the prostate. J Nat Cancer Inst 1991; 83: 329–335
   PubMedGoogle Scholar
• Cooner W H, Mosley B R, Rutherford CL, Jr, et al. Prostate cancer detection in a clinical practice by sonography, digital rectal examination and prostate specific antigen. JUrol 1990; 143: 1146–1152
   Google Scholar
• Catalona W J, Smith D S, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening for prostate cancer. NewEng JMed 1991; 324: 1156–1161
   PubMed Web of Science ®Google Scholar
• Killian CS, MingChu T. Prostate-specific antigen: Questions often asked. Cancer Invest 1990; 8: 27–37
   PubMed Web of Science ®Google Scholar